View Older Stories View More Recent Stories
-
Envoy Medical receives Nasdaq listing extension until February 2026
-
Envoy Medical Receives Positive Listing Determination from NASDAQ
-
Envoy Medical (COCH) files for 15.12M share offering by selling stockholders
-
Envoy Medical closes $16 million registered direct offering
-
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Envoy Medical raises $4 million in registered direct offering
-
Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates
-
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Envoy Medical gets FDA approval to advance cochlear implant trial
-
Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
-
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
-
Envoy Medical closes $2.5M stock offering at $1.31 per share
-
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
-
Envoy Medical raises $2.5 million in registered direct offering
-
Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology
-
Envoy Medical eliminates $32 million debt, advances clinical trial
-
Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments
-
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
-
Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025
-
Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant
-
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
-
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
-
Envoy Medical Reports on Second Quarter 2025 Results
-
Envoy Medical receives two new US patents for cochlear implant technology
-
Envoy Medical Expands Patent Portfolio with New Issuances in the United States
-
Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia
-
New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical
-
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up
-
Envoy Medical (COCH) Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
-
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
-
Envoy Medical Reports on First Quarter 2025 Results
-
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
-
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
-
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
-
Envoy Medical to Participate in the 37th Annual ROTH Conference
-
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
-
Envoy Medical (COCH) Secures Additional Patent Protection for Its Growing Patent Portfolio
-
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
-
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
-
Envoy Medical (COCH) Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
-
Envoy Medical (COCH) PT Lowered to $6 at Brookline Capital Markets
-
Envoy Medical (COCH): AMA Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem Device
-
Envoy Medical (COCH) Files $75M Mixed Shelf
-
Envoy Medical (COCH) PT Raised to $8.75 at Ascendiant Capital
-
Ascendiant Capital Starts Envoy Medical (COCH) at Buy
